Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly

Author(s): Ornella Corazza, Fabrizio Schifano, Magi Farre, Paolo Deluca, Zoe Davey, Colin Drummond, Marta Torrens, Zsolt Demetrovics, Lucia Di Furia, Liv Flesland, Barbara Mervo, Jacek Moskalewicz, Agnieszka Pisarska, Harry Shapiro, Holger Siemann, Arvid Skutle, Cinzia Pezzolesi, Peer Van Der Kreeft, Norbert Scherbaum.

Journal Name: Current Clinical Pharmacology

Volume 6 , Issue 2 , 2011

Become EABM
Become Reviewer

Abstract:

Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b]difuran-4-yl)-2-aminopropane; ‘ B-fly’). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon

Keywords: ABDF, Bromo-Dragonfly, FLY-compounds, internet monitoring, phenethylamines, designer drugs, ReDNet project, research chemicals, psychoactive drugs

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 6
ISSUE: 2
Year: 2011
Page: [125 - 129]
Pages: 5
DOI: 10.2174/157488411796151129
Price: $58

Article Metrics

PDF: 7

Special-new-year-discount